(Finance) – “We are extremely satisfied to be able to open our capital through stock market listing. The our business model of the Venture Builder, innovative, and also pioneering in Italy, is predestined to welcome more and more investors“. He stated this Philip SuraceCEO and founder of Cube Labs, commenting on the admission to trading of ordinary shares and warrants on the Euronext Growth Milan market – Professional Segment. The start of negotiations is scheduled for March 21, 2023.
“This is an important milestone for the world of Italian scientific research towards the capital market and the collection allows us to drive forward the development in health technologies also rewarding the team’s work done so far”, added Surace.
L’amount the total placement, entirely as a capital increase, amounted to approximately 4,105,000 euro, which was attended by institutional investors, professionals and industrial operators in the sector. The shares placed amounted to 2,052,500 at a price of 2.00 euro per share for a total value of 4,105,000 euro. There capitalization is equal to 34,105,000 euros, with a floating by 12.04%.
The operation also provides for the issue of 2,052,500 warrants to be assigned free of charge in the ratio of n. 1 Warrant every n. 1 share subscribed as part of the placement.
In the process of listing Cube Labs is assisted by MIT SIMas Euronext Growth Advisor, EnVent Capital Markets, as Global Coordinator, ADVANT Nctm, as Legal Counsel, 4AIM SICAF And Ambromobiliare as Financial Advisor, by Ria Grant Thornton as Auditing Firm, by Bernoni Grant Thornton as Tax Advisor, by Clarkson Hyde, as Consultant responsible for the circulation of non-accounting data.
(Photo: © Simona Flamigni | 123RF)